(Sharecast News) - 4basebio said on Monday that it had commercially launched a high-capacity single-stranded DNA product line aimed at supporting the development of gene editing, cell engineering and nucleic acid-based medicines.
The AIM-traded synthetic DNA manufacturer said the platform was built on its proprietary enzymatic manufacturing process and was designed...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE